肿瘤体积在宫颈癌近距离治疗中的研究进展

doi:10.11904/j.issn.1002-3070.2023.01.011

实用肿瘤学杂志 ›› 2023, Vol. 37 ›› Issue (1): 63-67.doi: 10.11904/j.issn.1002-3070.2023.01.011

肿瘤体积在宫颈癌近距离治疗中的研究进展

李书桢, 蔡志福, 容雁, 庞业滨, 罗冬妮综述, 高琨审校

广西医科大学附属肿瘤医院妇瘤科(南宁 530021)

收稿日期:2022-11-30 修回日期:2023-01-04 出版日期:2023-02-28 发布日期:2023-03-21
通讯作者: 高琨,E-mail:kungaomail@126.com
作者简介:李书桢,男,(1987-),硕士,主治医师,从事妇科肿瘤临床方面的研究。
基金资助:
广西壮族自治区卫生健康委员会自筹经费科研课题(编号:Z20210600);广西医疗卫生适宜技术开发与推广应用项目(编号:S2020096);广西壮族自治区临床重点专科建设项目经费资助

Research progress of tumor volume in cervical cancer brachytherapy

LI Shuzhen, CAI Zhifu, RONG Yan, PANG Yebin, LUO Dongni, GAO Kun

Department of Gynecologic Oncology,Affiliated Tumor Hospital of Guangxi Medical University,Nanning 530021,China

Received:2022-11-30 Revised:2023-01-04 Online:2023-02-28 Published:2023-03-21

摘要/Abstract

摘要： 肿瘤体积对于宫颈癌近距离治疗方式选择、危及器官剂量、局部控制率和生存预后有着重要的影响。随着靶向治疗、免疫治疗的快速发展,靶向治疗、免疫治疗和同期化疗联合外照射放疗,在实现近距离治疗前最大的肿瘤体积减少率以及个体化治疗上显示出巨大的临床应用前景。因此,本文针对近年肿瘤体积在宫颈癌近距离治疗中的研究进展进行了梳理和总结。

关键词: 宫颈肿瘤, 肿瘤体积, 近距离放射疗法, 进展

Abstract: Tumor volume has an important impact on the choice of brachytherapy method,dose to organs at risk,local control rate,and survival prognosis in cervical cancer.With the rapid development of targeted therapy and immunotherapy,targeted therapy,immunotherapy and concurrent chemotherapy combined external beam radiotherapy shows great clinical application prospects in the maximum tumor volume reduction rate before brachytherapy and realize individualized treatment.Therefore,this paper reviews and summarizes the research progress of tumor volume in brachytherapy of cervical cancer in recent years.

Key words: Cervical neoplasm, Tumor volume, Brachytherapy, Progress

中图分类号:

R737.33

李书桢, 蔡志福, 容雁, 庞业滨, 罗冬妮, 高琨. 肿瘤体积在宫颈癌近距离治疗中的研究进展[J]. 实用肿瘤学杂志, 2023, 37(1): 63-67.

LI Shuzhen, CAI Zhifu, RONG Yan, PANG Yebin, LUO Dongni, GAO Kun. Research progress of tumor volume in cervical cancer brachytherapy[J]. Journal of Practical Oncology, 2023, 37(1): 63-67.

参考文献

1 张艺艺,李奇,刘旭,等.宫颈癌患者五年生存及影响因素分析[J].实用肿瘤学杂志,2022,36(1):7-13.
2 刘龑昊,王俊杰.复发宫颈癌近距离治疗进展[J].中华放射肿瘤学杂志,2021,30(3):297-300.
3 Mayr NA,Taoka T,Yuh WT,et al.Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging[J].Int J Radiat Oncol Biol Phys,2002,52(1):14-22.
4 Lee KC,Kim HJ,Sung K,et al.The predictive value of tumor size,volume,and markers during radiation therapy in patients with cervical Cancer[J].Int J Gynecol Cancer,2017,27(1):123-130.
5 Chen W,Xiu S,Xie X,et al.Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer[J].Radiat Oncol,2022,17(1):6.
6 Van DL,De RM,Storme GA.Imaging in radiotherapy[J].Eur J Radiol,2000,36(1):41-48.
7 李文彬,李明华,崔雪娥,等.MRI的ROI体积测量法和直径体积测量法对宫颈癌放疗效果的临床实用性评价[J].实用放射学杂志,2004,20(7):629-632.
8 鲁玥玥,孙洪赞,马全美,等.宫颈癌¹⁸F-FDG PET与MR体积测量一致性探讨的PET/MR研究[J].中国临床医学影像杂志,2018,29(2):112-117.
9 Kruser TJ,Bradley KA,Bentzen SM,et al.The impact of hybrid PET-CT scan on overall oncologic management,with a focus on radiotherapy planning:a prospective,blinded study[J].Technol Cancer Res Treat,2009,8(2):149-158.
10 万虹,王胜军,马福成.宫颈癌¹⁸F-FDG PET/CT、增强CT及病理体积的对比研究[J].中国临床研究,2014,27(1):13-15.
11 江萍,张福泉,程光惠,等.复发宫颈癌近距离治疗专家共识[J].中华放射肿瘤学杂志,2020,29(9):721-729.
12 Marchiolé P,Buénerd A,Benchaib M,et al.Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer:a retrospective case-control surgico-pathological study[J].Gynecol Oncol,2005,97(3):727-732.
13 许雨虹,陈传本.调强放疗时代原发肿瘤体积对鼻咽癌预后的影响[J].中国医药科学,2020,10(20):195-198.
14 刘叶红,郭旗,田野.宫颈癌腹主动脉旁淋巴引流区预防性放疗的研究现状[J].中华放射肿瘤学杂志,2019,28(2):146-150.
15 Windschall A,Ott OJ,Sauer R,et al.Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma[J].Strahlenther Onkol,2005,181(8):545-550.
16 Lee JH,Lee SW,Kim JR,et al.Tumour size,volume,and marker expression during radiation therapy can predict survival of cervical cancer patients:a multi-institutional retrospective analysis of KROG 16-01[J].Gynecol Oncol,2017,147(3):577-584.
17 Tewari KS,Monk BJ.Evidence-based treatment paradigms for management of invasive cervical carcinoma[J].J Clin Oncol,2019,37(27):2472-2489.
18 Murakami N,Ando K,Murata M,et al.Why not de-intensification for uterine cervical cancer?[J].Gynecol Oncol,2021,163(1):105-109.
19 Yoshida K,Yamazaki H,Kotsuma T,et al.Simulation analysis of optimized brachytherapy for uterine cervical cancer:Can we select the best brachytherapy modality depending on tumor size?[J].Brachytherapy,2016,15(1):57-64.
20 张宁,赵志鹏,程光惠,等.局部晚期宫颈癌腔内联合组织间插植3D-IGBT的剂量学研究[J].中华放射肿瘤学杂志,2015,24(3):267-270.
21 陈俊安,刘文君,罗然,等.宫颈癌近距离放疗应用进展[J].现代肿瘤医学,2022,30(8):1512-1516.
22 修雨婷,孟凡旭,王琢,等.后装腔内联合组织间插植在ⅢB期宫颈癌中剂量学及疗效分析[J].中华放射肿瘤学杂志,2022,31(6):539-543.
23 Isohashi F,Mabuchi S,Akino Y,et al.Dose-volume analysis of predictors for chronic gastrointestinal complications in patients with cervical cancer treated with postoperative concurrent chemotherapy and whole-pelvic radiation therapy[J].J Radiat Res,2016,57(6):668-676.
24 Kirchheiner K,Pötter R,Tanderup K,et al.Health-related quality of life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy:an analysis from the EMBRACE study[J].Int J Radiat Oncol Biol Phys,2016,94(5):1088-1098.
25 孙畅,路顺,张菡奕,等.肿瘤体积及瘤体缩减率在同步放化疗的宫颈癌患者预后中的价值[J].肿瘤预防与治疗,2019,32(5):421-428.
26 赵志鹏,管薇,赵红福,等.3D打印模板辅助标准化施源器在ⅢB期宫颈癌影像引导自适应近距离治疗中的应用[J].中华放射肿瘤学杂志,2020,29(8):661-665.
27 Zhang N,Tang Y,Guo X,et al.Analysis of dose-effect relationship between DVH parameters and clinical prognosis of definitive radio(chemo)therapy combined with intracavitary/interstitial brachytherapy in patients with locally advanced cervical cancer:a single-center retrospective study[J].Brachytherapy,2020,19(2):194-200.
28 路顺,范子煊,孙畅,等.IMRT同步剂量补偿高剂量率后装治疗大体积宫颈癌的疗效分析[J].中华放射肿瘤学杂志,2019,28(7):522-526.
29 Yang H,Zhang Y,Liu C,et al.The integration of bevacizumab improves tumor response and survival in patients with refractory cervical cancer treated with radical chemoradiotherapy[J].Ann Transl Med,2021,9(14):1184.
30 杨华,魏丽春,张莹,等.联合贝伐珠单抗新辅助化疗＋同步放化疗治疗局部晚期巨块型宫颈癌的初步临床研究[J].中华放射肿瘤学杂志,2021,30(4):372-375.
31 高颜凤,温坚,庄茜茹.贝伐珠单抗联合同步放化疗治疗局部晚期宫颈癌的效果观察[J].中国肿瘤临床与康复,2022,29(6):713-716.
32 Mauricio D,Zeybek B,Tymon-Rosario J,et al.Immunotherapy in cervical cancer[J].Curr Oncol Rep,2021,23(6):61.
33 Lan C,Shen J,Wang Y,et al.Camrelizumab plus apatinib in patients with advanced cervical cancer(CLAP):a multicenter,open-label,single-arm,phase II trial[J].J Clin Oncol,2020,38(34):4095-4106.
34 王娟,陈大卫,于金明.放射远隔效应的量变到质变-布拉格治疗[J].中华肿瘤防治杂志,2022,29(18):1314-1316.

[1]	吴蕊玥, 朱凯丽, 杨景茹, 令晓玲. HER2低表达乳腺癌的临床研究进展[J]. 实用肿瘤学杂志, 2022, 36(6): 570-575.
[2]	陈俊慧, 刘思雨, 贺长军. RUNX1在肺癌中的研究进展[J]. 实用肿瘤学杂志, 2022, 36(6): 576-579.
[3]	张艺艺, 李奇, 刘旭, 王亚楠, 邹沅杰, 周慧慧, 徐春燕, 苏升琦, 葛鑫, 王铜. 宫颈癌患者五年生存及影响因素分析[J]. 实用肿瘤学杂志, 2022, 36(1): 7-13.
[4]	赵轩, 李国东, 刘明. 金属硫蛋白在大肠癌中的研究进展[J]. 实用肿瘤学杂志, 2021, 35(6): 538-541.
[5]	赵浩然, 李满, 张玉宝. 肝细胞癌相关RNA结合蛋白研究进展[J]. 实用肿瘤学杂志, 2021, 35(6): 576-579.
[6]	黎敏, 冉立, 常建英. 影像学技术在图像引导宫颈癌近距离放射治疗中的应用[J]. 实用肿瘤学杂志, 2021, 35(3): 263-267.
[7]	胡洋, 张清媛. PARP抑制剂治疗BRCA1/2突变转移性乳腺癌的研究进展[J]. 实用肿瘤学杂志, 2021, 35(2): 184-187.
[8]	郭永东, 靳晶, 李利敏, 贺宇彤. 分化拮抗非蛋白质编码RNA(DANCR)在常见恶性肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2020, 34(1): 69-73.
[9]	李国政, 庞达. HER2阳性乳腺癌治疗的研究进展[J]. 实用肿瘤学杂志, 2020, 34(1): 74-78.
[10]	许健, 詹月萍, 蒋元烨, 曹勤. α-常春藤皂苷的抗肿瘤药理作用研究进展[J]. 实用肿瘤学杂志, 2019, 33(6): 553-556.
[11]	李素素, 周春祥. NKT细胞对肝癌免疫应答的双向调控作用[J]. 实用肿瘤学杂志, 2019, 33(6): 540-543.
[12]	李珊,赵春波,乔文波. 术中放疗在胰腺癌中的应用进展[J]. 实用肿瘤学杂志, 2019, 33(3): 280-283.
[13]	张宝综述, 郑志超校审. 进展期胃癌淋巴结清扫研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 78-81.
[14]	吴启润, 罗婷, 王鹏, 徐克. 营养支持方式在肿瘤晚期患者中应用现状及展望[J]. 实用肿瘤学杂志, 2018, 32(4): 381-384.
[15]	庄敏敏, 张云艳. ICAM-1在肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(1): 82-86.

肿瘤体积在宫颈癌近距离治疗中的研究进展

Research progress of tumor volume in cervical cancer brachytherapy

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价